Document is current
Any future updates will be listed below
-
Authors
Hew, Lois https://orcid.org/0000-0002-0183-8177
Maierhof, Smilla K.
Ivanov, Andranik
Beule, Dieter
Fernandez Vallone, Valeria
Stachelscheid, Harald https://orcid.org/0000-0002-9283-4605
Frahm, Silke https://orcid.org/0000-0001-5645-2557
Telugu, Narasimha Swamy
Endres, Matthias https://orcid.org/0000-0001-6520-3720
Boehmerle, Wolfgang https://orcid.org/0000-0001-7195-3894
Huehnchen, Petra https://orcid.org/0000-0002-6825-7270
Schinke, Christian https://orcid.org/0000-0003-0199-9672
- License Information
-
More Information
Article History
Received: 2 May 2025
Revised: 8 October 2025
Accepted: 28 October 2025
First Online: 13 November 2025
Competing interests
: ME reports grants from Bayer and Ipsen and fees paid to the Charité from Amgen, AstraZeneca, Bayer, Bristol Myers Squibb and Daiichi Sankyo; all outside the submitted work. All authors declare that they have no competing interests.
: This study was conducted in accordance with the Declaration of Helsinki and its amendments. It was approved by the ethics committee of Charité – Universitätsmedizin Berlin [EA4/069/14]. Written informed consent was obtained from the participants from whom stem cells were derived prior to the study.
